When cells were preincubated with CPZ and MβCD, the infection percentages decreased from 7.00% to 2.36% and 1.65% in 0, 25, and 50 μg/mL CPZ-treated cells, respectively (Figure 5B pre-MβCD), and the infection rate was significantly decreased to ~33.7% and 23.6%. This evidence concerns the gene CPZ and infection.